Director received an award of 52 WST derivative securities | OQRO Insider trades- Derivative units · @ $250.64
Why it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Mar 31, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Apr 1, 2026
DirectorGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000105770-26-000043
- Filed / recorded
Apr 1, 2026, 6:17 PM UTCAdded to OQROOct 2, 2026, 12:29 PM UTC Data qualityVerified: identifiers matched exactly IssuerWEST PHARMACEUTICAL SERVICES INC Reporting personJanet Brutschea Haugen SecurityPhantom Stock Unit TableDerivative (Table II) Transaction dateMar 31, 2026 Acquired / disposedAcquired (A) Shares owned after260.494 Footnotes from the filing
- Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director.
Around the same time
Derivative exercise or conversion — not an open-market buy.
20K → 17K shares held−14% of their stake
West Pharmaceutical Services's Sr. VP & Chief HR Officer sold $860K of West Pharmaceutical Services shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.